Image de couverture de livre

Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Joanna Waldock, Rebecca J. Cox, Othmar G. Engelhardt, Stephanie Ascough, Albert Osterhaus, Guus F. Rimmelzwaan, Martin Ludlow, John S. Tregoning, Jacqueline U. McDonald, Ursula J. Buchholz, Rienk E. Jeeninga, Charles. Sande, Christopher Chiu
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Influenza and Other Respiratory Viruses
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Impact of Nirsevimab on RSV and Non‐RSV Severe Respiratory Infections in Hospitalized Infants
par: María Luz García‐García, et autres
Publié: (2025)

Evaluating the Impact of Different Methods on the Timing and Duration of RSV Epidemics: Analysis of Surveillance Data From the GERi (Global Epidemiology of RSV in Hospitalized and Community Care) Study
par: Lisa Staadegaard, et autres
Publié: (2025)

Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV
par: Atsuko Yamamoto, et autres
Publié: (2024)

Assessing the Impact of Non‐Pharmaceutical Interventions During the COVID‐19 Pandemic on RSV Seasonality in Europe
par: Susanne Heemskerk, et autres
Publié: (2025)

An Improved Rapid and Sensitive Long Amplicon Method for Nanopore‐Based RSV Whole‐Genome Sequencing
par: Xiaomin Dong, et autres
Publié: (2025)

Correction to “Assessing the Impact of Non‐Pharmaceutical Interventions During the COVID‐19 Pandemic on RSV Seasonality in Europe”
Publié: (2025)

Bridging Genomics and Clinical Medicine: RSVrecon Enhances RSV Surveillance With Automated Genotyping and Clinically Important Mutation Reporting
par: Lei Li, et autres
Publié: (2026)

Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review
par: Richard Osei‐Yeboah, et autres
Publié: (2024)

RSV Disease Burden in Primary Care in Italy: A Multi‐Region Pediatric Study, Winter Season 2022–2023
par: Michela Scarpaci, et autres
Publié: (2024)

Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season
par: Daniel Aguilar Figueroa, et autres
Publié: (2025)

Comparison of the Burden and Temporal Pattern of Hospitalisations Associated With Respiratory Syncytial Virus (RSV) Before and After COVID‐19 in New Zealand
par: Nikki Turner, et autres
Publié: (2024)

Disease Burden of RSV Infections and Bronchiolitis in Young Children (< 5 Years) in Primary Care and Emergency Departments: A Systematic Literature Review
par: Susanne Heemskerk, et autres
Publié: (2024)

Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)]
par: G. Sever Yildiz, et autres
Publié: (2024)

Introducing the Concept of Small Vulnerable Newborns (SVN) as an Additional Endpoint to Evaluate Birth Outcomes in the Context of RSV Immunization Studies—A Commentary
par: Jacob Gerstenberg, et autres
Publié: (2026)

Correction to: The Respiratory Syncytial Virus Prefusion F Protein Vaccine Attenuates the Severity of RSV‐Associated Disease in Breakthrough Infections in Adults ≥60 Years of Age
Publié: (2024)

Nirsevimab Effectiveness Against RSV‐Related Hospitalisations in Children Under 24 Months: A Test‐Negative Case–Control Study in Portugal, 2024–2025
par: Vânia Gaio, et autres
Publié: (2025)

RSV Disease Burden in Older Adults: An Italian Multiregion Pilot Study of Acute Respiratory Infections in Primary Care Setting, Winter Season 2022–2023
par: Sara Bracaloni, et autres
Publié: (2024)

Incidence of RSV‐ and Influenza‐Associated Hospitalizations With Community‐Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022–2024: APSG‐J2 Study
par: Haruka Maeda, et autres
Publié: (2026)

A Randomized, Double‐Blind, Placebo‐Controlled, Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Single Vaccination of Ad26.RSV.preF‐Based Regimen in Japanese Adults Aged 60 Years and Older
par: Takashi Eto, et autres
Publié: (2024)

Rapid and Safe Neutralization Assay for Circulating H5N1 Influenza Virus in Dairy Cows
par: Kei Miyakawa, et autres
Publié: (2024)

A Monoclonal Antibody ELISA–Based Assay for Measuring the Potency of Candidate H5 Clade 2.3.4.4b Pandemic Influenza Vaccines
par: Marcus Odin, et autres
Publié: (2026)

Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study
par: Susana Monge, et autres
Publié: (2024)

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
par: Lore Merdrignac, et autres
Publié: (2024)

Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024
par: Liliana Antunes, et autres
Publié: (2025)

Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019–2020 Season in Philadelphia, Pennsylvania
par: Lydia M. Mendoza, et autres
Publié: (2025)

Evaluating Bacillus Calmette–Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice
par: Sijing Yan, et autres
Publié: (2025)

Neurologic Complications of Influenza and Potential Protective Vaccine Effects
par: Ann R. Falsey
Publié: (2025)

Age‐Related Asymptomatic Rhinovirus Infections Contribute to the Sustained Prevalence in Adults and Are Not Mitigated by Nonpharmaceutical Interventions
par: Dong Wei, et autres
Publié: (2026)

Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025
par: Daniel Evans, et autres
Publié: (2026)

High Infection Risk Among Health Care Workers During the First SARS‐CoV‐2 Wave in Niamey, Niger
par: Hamidou Lazoumar Ramatoulaye, et autres
Publié: (2025)

Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study
par: Kristoffer Grundtvig Skaarup, et autres
Publié: (2025)

Incidence of Hospitalization due to Influenza‐Associated Severe Acute Respiratory Infection During 2010–2019 in Bangladesh
par: Mohammad Abdul Aleem, et autres
Publié: (2024)

Changes in the Epidemiology of Influenza and Respiratory Syncytial Virus During 2020–2022 Relative to the Pre‐COVID‐19 Pandemic Period (2017–2020) From Systematic Sentinel Syndromic Surveillance in South Africa
par: Sibongile Walaza, et autres
Publié: (2026)

Longitudinal SARS‐CoV‐2 Antibody Response in Healthcare Workers: Benefit of Prior Infection and Heterologous Boosting on Anti‐Spike IgG Immunity
par: Els Van Nedervelde, et autres
Publié: (2026)

Issue Information
Publié: (2025)

Influenza Epidemiology in Finland During and After the COVID‐19 Pandemic: Surveillance Data Analysis (2019–2024)
par: Ulrike Baum, et autres
Publié: (2025)

Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain
par: Matilde Zornoza Moreno, et autres
Publié: (2024)

Correction to “The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019–2023”
Publié: (2026)

The Second Round of a Population‐Based Seroprevalence Study of Anti–SARS‐CoV‐2 Antibodies and COVID‐19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina
par: Jela Aćimović, et autres
Publié: (2025)

SARS‐CoV‐2 Viral Load and Cytokine Dynamics Profile as Early Signatures of Long COVID Condition in Hospitalized Individuals
par: Jacobo Alonso Domínguez, et autres
Publié: (2025)